FibroGen (FGEN) Tops Q1 EPS by 11c

FibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.45), $0.11 better than the analyst estimate of ($0.56).

At March 31, 2016, FibroGen had $309.9 million of cash, cash equivalents, investments, receivables and restricted cash

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• HSBC upgrades EU stocks, downgrades EM on increased volatility
• Penguin Solutions (PENG) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY26 EPS Guidance
• Samsung 2q Oper Profit 89.40t Won, Est. 84.2t Won